What Factors Are Escalating the Demand Across the US Lymphedema Treatment Market?
The increasing prevalence of lymphedema and the growing awareness of treatment options have propelled substantial expansion in the US healthcare domain. According to detailed industry evaluation of the US Lymphedema Treatment Market, the market was valued at USD 123.38 million in 2024 and is projected to reach USD 278 million by 2035, exhibiting a CAGR of 7.67% during the forecast period...
0 Reacties 0 aandelen 0 voorbeeld